Claudia Dosi

Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose et al. · The Lancet Neurology · 2022 · 96 citations · Full text

Type 1, Firefish Part 2, Rehabilitation +6

Next-generation sequencing approach to hyperCKemia

Anna Rubegni, Alessandro Malandrini, Claudia Dosi et al. · Neurology Genetics · 2019 · 45 citations · Full text

Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies

Marika Pane, Beatrice Berti, Anna Capasso et al. · EClinicalMedicine · 2023 · 39 citations · Full text

Comorbidities of sleep disorders in childhood and adolescence: focus on migraine

Oliviero Bruni, Claudia Dosi, Assia Riccioni et al. · Nature and Science of Sleep · 2013 · 26 citations · Full text

Identification of a cytokine profile in serum and cerebrospinal fluid of pediatric and adult spinal muscular atrophy patients and its modulation upon nusinersen treatment

Silvia Bonanno, Paola Cavalcante, Erika Salvi et al. · Frontiers in Cellular Neuroscience · 2022 · 26 citations · Full text